U.S. market Closed. Opens in 16 hours 58 minutes

AEON | AEON Biopharma, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2022-12-312021-12-312020-12-312019-12-31
RevenueN/AN/A2.52M3.36M
Cost of RevenueN/AN/AN/A1.00K
Gross ProfitN/AN/A2.52M3.36M
Operating Expenses48.43M36.88M18.91M51.73M
Selling, General & Admin13.68M11.15M11.59M46.04M
Research & Development34.75M25.73M7.32M4.81M
Other Operating Expenses-4.13M10.21M-5.61M-10.75M
Operating Income-48.43M-65.85M-16.39M-53.97M
Other Expenses / Income-4.13M-18.76M-16.51M200.79M
Before Tax Income-52.56M-55.64M-32.91M145.67M
Income Tax Expenses-160.49K28.97M15.00K-14.64M
Net Income-52.56M-55.64M-32.91M172.92M
Interest ExpensesN/AN/A15.00K7.47M
Basic Shares OutstandingN/A22.00M14.80M14.80M
Diluted Shares OutstandingN/A22.00M14.80M14.80M
EBITDA-48.36M-7.91M-22.14M-50.41M
EBITDA Margin0.00%0.00%-879.35%-1,501.61%
EBIT-52.72M-26.67M-32.88M165.75M
EBIT Margin0.00%0.00%-1,305.92%4,937.30%
Financial Year End2022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙